Abstract
Epidemiological studies have suggested a correlation between consumption of carotenoid-rich food and incidence of chronic diseases. In this review chemical structure, bioavailability and mechanisms of action of carotenoids most represented in human diet, mainly ß-carotene and lycopene, are reported, with focus on results obtained with cells in culture.
Keywords: Carotenoids, in vitro cell models, antioxidant, connexins, cancer
Mini-Reviews in Medicinal Chemistry
Title: Beneficial or Detrimental Effects of Carotenoids Contained in Food: Cell Culture Models
Volume: 7 Issue: 11
Author(s): G. Ranaldi, D. Bellovino, P. Palozza and S. Gaetani
Affiliation:
Keywords: Carotenoids, in vitro cell models, antioxidant, connexins, cancer
Abstract: Epidemiological studies have suggested a correlation between consumption of carotenoid-rich food and incidence of chronic diseases. In this review chemical structure, bioavailability and mechanisms of action of carotenoids most represented in human diet, mainly ß-carotene and lycopene, are reported, with focus on results obtained with cells in culture.
Export Options
About this article
Cite this article as:
Ranaldi G., Bellovino D., Palozza P. and Gaetani S., Beneficial or Detrimental Effects of Carotenoids Contained in Food: Cell Culture Models, Mini-Reviews in Medicinal Chemistry 2007; 7 (11) . https://dx.doi.org/10.2174/138955707782331704
DOI https://dx.doi.org/10.2174/138955707782331704 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Small Non-Coding RNAs as Biomarkers
Recent Patents on Biomarkers The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators
CNS & Neurological Disorders - Drug Targets Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment
Current Cancer Therapy Reviews The Role of Endogenous H2S in Cardiovascular Physiology
Current Pharmaceutical Biotechnology Insights into the Structure, Function, and Regulation of Human Cytochrome P450 1A2
Current Drug Metabolism Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma
Current Pharmaceutical Design Metal Containing Chloroquinolines: Beyond Hit and Miss Antimalarial Efficacy to Solid Science
Mini-Reviews in Medicinal Chemistry The Development of Copper Radiopharmaceuticals for Imaging and Therapy
Medicinal Chemistry Synthesis and <i>In silico</i> Studies of Quinazolinone Derivatives as PARP-1 Inhibitors
Letters in Drug Design & Discovery Radiolabeled Imaging Probes Targeting Angiogenesis for Personalized Medicine
Current Pharmaceutical Design Genetics of Preneoplasia: Lessons from Lung Cancer
Current Molecular Medicine Multifunctional Radiolabeled Nanoparticles for Targeted Therapy
Current Medicinal Chemistry Screening of Potential Plant Compounds as Survivin Inhibitors and its Anti-Cancer Efficacy by Molecular Docking
Current Enzyme Inhibition Microsomal Prostaglandin E Synthase: A Key Enzyme in PGE2 Biosynthesis and Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Personalized Therapies in Pediatric Inflammatory and Autoimmune Diseases
Current Pharmaceutical Design Role of ncRNAs in Development, Diagnosis and Treatment of Human Cancer
Recent Patents on Anti-Cancer Drug Discovery Omacetaxine as an Anticancer Therapeutic: What is Old is New Again
Current Pharmaceutical Design Targeting Signaling Pathways in Chronic Lymphocytic Leukemia
Current Cancer Drug Targets Competition Between Tumor and Mononuclear Phagocyte System Causing the Low Tumor Distribution of Nanoparticles and Strategies to Improve Tumor Accumulation
Current Drug Delivery